Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTC| |TTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGG
End
70374428/70147296 (Hg38)
Nearest miRNA
hsa-mir-1301/Upstream/1043541; hsa-mir-10b/Downstream/105622;
Upstream sequence
TGTGGTTATTCCTTCTCTTTTAGAGGCATAGTACCTCTCTTACCAAAAATGTCTCCCCCTCTGTTAGGCCAATCAGTGCCTTTTTGGGGGCTGGGAGGGG
Downstream sequence
TTCTGCCTTTTGGATCAGAGAGTGGAGCAGTGAGTCCTGCTCCAGTGAGGAAGCCATACATTCAGGCACTTCAGGAGCCAGAATTCCTACTAGGGGAGCT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.